Tumors, via the expression of GFRα1, GFRα2, GFRα3, respond to molecules released by nerves and, in an autocrine fashion, to molecules released by the tumor itself and these interactions are likely amplified in the tumor microenvironment. The gene discussed is GFRA3; the disease is neoplasm.